Corporate News
Aurobindo Pharma approves transfer of its generic formations products biz to Auropharm As on : 06-Apr-26  09:05

The board of Aurobindo Pharma at its meeting held on 06 April 2026 has approved the transfer of the Company's domestic branded generic pharmaceutical formulations products business on a going concern basis through a Business Transfer Agreement (BTA) to Auropharm (previously known as Auro Pharma), a wholly owned subsidiary of the Company. It is in line with the Company's strategy in further streamlining and accelerating Company's domestic business for faster growth.